# Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)

> **NCT00725452** · — · COMPLETED · sponsor: **Merck Sharp & Dohme LLC** · enrollment: 26 (actual)

## Conditions studied

- Psoriasis

## Interventions

- **BIOLOGICAL:** Infliximab

## Key facts

- **NCT ID:** NCT00725452
- **Lead sponsor:** Merck Sharp & Dohme LLC
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2006-10
- **Primary completion:** 2010-06
- **Final completion:** 2010-06
- **Target enrollment:** 26 (ACTUAL)
- **Last updated:** 2015-07-28

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00725452

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00725452, "Five-Year Observation of Remicade Treatment for Plaque Psoriasis in Austria (Study P04900)". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00725452. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*